CVE-2026-24164: NVIDIA BioNeMo RCE Vulnerability

CVE-2026-24164 Overview

NVIDIA BioNeMo contains a critical insecure deserialization vulnerability that allows an attacker to exploit the platform through processing of untrusted serialized data. When successfully exploited, this vulnerability could enable remote code execution, denial of service, information disclosure, and data tampering, making it a significant security concern for organizations utilizing BioNeMo for computational biology and drug discovery workflows.

Critical Impact

Successful exploitation could lead to arbitrary code execution, complete system compromise, unauthorized access to sensitive research data, and disruption of computational biology workflows.

Affected Products

• NVIDIA BioNeMo

Discovery Timeline

• 2026-03-31 - CVE-2026-24164 published to NVD
• 2026-04-01 - Last updated in NVD database

Technical Details for CVE-2026-24164

Vulnerability Analysis

This vulnerability is classified under CWE-502 (Deserialization of Untrusted Data), which occurs when an application deserializes data from an untrusted source without adequate validation. In the context of NVIDIA BioNeMo, the deserialization mechanism fails to properly validate input before processing, allowing malicious payloads embedded in serialized objects to execute during the deserialization process.

The network-based attack vector requires user interaction, suggesting the vulnerability may be triggered through actions such as loading a maliciously crafted model file, importing tainted research data, or processing specially crafted API requests. The potential for code execution, denial of service, information disclosure, and data tampering indicates the vulnerability provides broad access to system resources once exploited.

Root Cause

The root cause stems from insecure deserialization practices within NVIDIA BioNeMo. The application processes serialized data without implementing proper input validation, type checking, or integrity verification. This allows attackers to craft malicious serialized objects that, when processed by the vulnerable component, execute arbitrary code or manipulate application state in unintended ways.

Attack Vector

The vulnerability is exploitable over the network and requires user interaction for successful exploitation. An attacker could deliver a malicious payload through several vectors:

1. Malicious Model Files: Crafting serialized model files containing embedded malicious code that executes upon loading
2. Tainted Research Data: Embedding exploit code within serialized data structures exchanged between BioNeMo components
3. API Request Manipulation: Sending specially crafted API requests containing malicious serialized objects

The deserialization process trusts the incoming data without sufficient validation, allowing the malicious payload to execute with the privileges of the BioNeMo application. For detailed technical information about this vulnerability, refer to the NVIDIA Support Article.

Detection Methods for CVE-2026-24164

Indicators of Compromise

• Unexpected process spawning from BioNeMo application components
• Anomalous network connections initiated by BioNeMo processes
• Unusual file system access patterns, particularly to sensitive directories
• Unexpected memory usage spikes during data loading operations

Detection Strategies

• Monitor BioNeMo application logs for deserialization errors or exceptions
• Implement network traffic analysis to detect suspicious serialized data patterns
• Deploy endpoint detection rules targeting known deserialization attack signatures
• Configure file integrity monitoring on BioNeMo configuration and model directories

Monitoring Recommendations

• Enable verbose logging for BioNeMo data processing operations
• Implement application-level monitoring for serialization/deserialization events
• Configure alerts for unusual API request patterns or payloads
• Monitor system resource utilization for anomalies during data loading operations

How to Mitigate CVE-2026-24164

Immediate Actions Required

• Review the NVIDIA Support Article for specific patch availability
• Restrict network access to BioNeMo instances to trusted sources only
• Implement input validation for all external data sources processed by BioNeMo
• Audit and review any recently loaded models or data files for suspicious content

Patch Information

NVIDIA has published security guidance for this vulnerability. Organizations should consult the NVIDIA Support Article for specific patch versions and update instructions. Apply vendor-provided patches as soon as they become available for your deployment environment.

Workarounds

• Implement network segmentation to isolate BioNeMo instances from untrusted networks
• Configure strict access controls limiting which users can load external data or models
• Deploy web application firewalls to filter potentially malicious serialized payloads
• Consider implementing allowlist-based validation for acceptable serialized object types

Organizations should prioritize applying vendor patches when available. Temporary workarounds should be considered interim measures until official patches can be deployed.